Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01214252 · ClinicalTrials.gov registry record
A Retrospective Study Evaluating the Use of Permacol Surgical Implant in the Repair of Abdominal Wall Defects
A clinical trial of Abdominal Wall Defects, sponsored by Medtronic - MITG.
- Completed
- Registry status
- 343
- Enrollment target
- 1
- Study location
NCT01214252: Completed study of Abdominal Wall Defects, sponsored by Medtronic - MITG.
NCT01214252 is a study of Abdominal Wall Defects that has completed, run by Medtronic - MITG. The registered enrollment target is 343 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01214252, a study of Abdominal Wall Defects, has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- 343 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate short, mid and long term clinical outcomes associated with the use of Permacol in the treatment of abdominal wall defects.
Primary Outcome
Confirmed hernia or hernia recurrence: Proportion of patients treated with Permacol Surgical Implant who experienced hernia or hernia recurrence at the repair site. Hernia or recurrence is defined by hernia diagnosis during clinical assessment by surgeon or medical chart review
Conditions Studied
Interventions
- DEVICE Permacol Surgical Implant
Study Locations (1)
Massachusetts
- Annie Choi - Bedford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 343 participants |
| Start Date | 2010-10 |
| Est. Completion | 2012-01 |
What the finished NCT01214252 record still lists
NCT01214252 is an observational study that tracks outcomes without assigning an intervention. The registered 343 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Abdominal Wall Defects appearing as the primary indexed condition, and to 1 intervention - of which Permacol Surgical Implant is the first listed.
NCT01214252 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01214252 about?
NCT01214252 is a clinical study titled "A Retrospective Study Evaluating the Use of Permacol Surgical Implant in the Repair of Abdominal Wall Defects". To evaluate short, mid and long term clinical outcomes associated with the use of Permacol in the treatment of abdominal wall defects.
What is the current status of trial NCT01214252?
This trial is currently completed. The enrollment target is 343 participants. The study started on 2010-10. Estimated completion is 2012-01.
What conditions does trial NCT01214252 study?
This clinical trial studies the following conditions: Abdominal Wall Defects.
What interventions are being tested in trial NCT01214252?
The interventions under investigation include: Permacol Surgical Implant (DEVICE).
Who is sponsoring clinical trial NCT01214252?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01214252 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06733363 · 344 participants · Phase 2
A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer
- NCT07179380 · 344 participants · Phase 3
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- NCT07304024 · 344 participants · Phase 1
A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound
- NCT05283850 · 342 participants · Phase 2
Surviving PEA in Roanoke (SPEAR) Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia